Clinical Trials
104 trialsNovel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
AstraZeneca
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Sun Yat-sen University
NOM-ERA
Washington University School of Medicine
Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer
Shandong Cancer Hospital and Institute
CLEAR-03
Fudan University
TRIUNITE06
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
FUDOSE
UNICANCER
CIME
Centre Leon Berard
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer
Fudan University
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
First Affiliated Hospital of Zhejiang University
TRIUNITE-08
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
Universitätsmedizin Mannheim
IMMUNOSTAR
Gruppo Oncologico Italiano di Ricerca Clinica
CATALIS
Shanghai Zhongshan Hospital
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Henan Cancer Hospital
A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation
Harbin Medical University
Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
The First Affiliated Hospital of Anhui Medical University
QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer
Qilu Hospital of Shandong University
Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
Fudan University
NePHera
Peking Union Medical College Hospital
Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer
Zhejiang Cancer Hospital
Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases
Asan Medical Center
Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer
Stanford University
An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
Bristol-Myers Squibb
To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer
Xijing Hospital of Digestive Diseases
Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer
Tang-Du Hospital
NO-CUT
Niguarda Hospital
AXOAXI
Helsinki University Central Hospital
REVISE
West China Hospital
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Zhejiang Cancer Hospital
Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer
Hebei Medical University Fourth Hospital
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
Tianjin Medical University Cancer Institute and Hospital
ADAGE
Federation Francophone de Cancerologie Digestive
AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
Harbin Medical University
SUNRISE
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Peking University
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
Sun Yat-sen University
A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
STRATEGIC-1
GERCOR - Multidisciplinary Oncology Cooperative Group
Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression
Henan Cancer Hospital
Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer
Tang-Du Hospital
EXPLORING
The First Affiliated Hospital with Nanjing Medical University
CRC - PTX
Tanta University
TESS
Sun Yat-sen University
IDEA
GERCOR - Multidisciplinary Oncology Cooperative Group
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
Chinese University of Hong Kong
KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma
Peking University Cancer Hospital & Institute
SIRTCI
Federation Francophone de Cancerologie Digestive
TRACE-LE
Fujian Medical University Union Hospital